• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生成纤维细胞生长因子23的间充质肿瘤

FGF23 Producing Mesenchymal Tumor.

作者信息

Papierska Lucyna, Cwikła Jarosław B, Misiorowski Waldemar, Rabijewski Michał, Sikora Krzysztof, Wanyura Hubert

机构信息

Clinic of Endocrinology, Medical Center of Postgraduate Education, Warsaw, Poland.

Department of Radiology, The Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland.

出版信息

Case Rep Endocrinol. 2014;2014:492789. doi: 10.1155/2014/492789. Epub 2014 Feb 3.

DOI:10.1155/2014/492789
PMID:24639905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3929986/
Abstract

A 40-year-old patient was referred to Clinic of Endocrinology due to hypophosphatemia causing pain, cramps, and weakness of muscles. Moreover, his bone mineral density was very low. The previous treatment with phosphorus and active vitamin D metabolites was ineffective. In lab tests the hypophosphatemia, hyperphosphaturia, and elevated FGF23 levels were found. Somatostatin receptor scintigraphy (SRS) showed increased radiotracer uptake in the right maxillary sinus and CT scans confirmed presence of tumor in this localization. Biopsy and cytological examination created suspicion of mesenchymal tumor-glomangiopericytoma. Waiting for surgery the patient was treated with long acting Somatostatine analogue, and directly before operation short acting Octreotide and intravenous phosphorus were used. Histology confirmed the cytological diagnosis and the phosphatemia return to normal values in 10 days after the tumor removal.

摘要

一名40岁患者因低磷血症导致疼痛、痉挛和肌肉无力,被转诊至内分泌科诊所。此外,他的骨矿物质密度非常低。先前使用磷和活性维生素D代谢物的治疗无效。实验室检查发现有低磷血症、高磷尿症和FGF23水平升高。生长抑素受体闪烁显像(SRS)显示右上颌窦放射性示踪剂摄取增加,CT扫描证实在该部位存在肿瘤。活检和细胞学检查怀疑为间叶性肿瘤——血管球性血管外皮细胞瘤。在等待手术期间,患者接受了长效生长抑素类似物治疗,在手术前直接使用了短效奥曲肽和静脉注射磷。组织学证实了细胞学诊断,肿瘤切除后10天血磷恢复到正常水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/e4482cc94b89/CRIM.ENDOCRINOLOGY2014-492789.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/53213d349311/CRIM.ENDOCRINOLOGY2014-492789.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/6e395ddfda23/CRIM.ENDOCRINOLOGY2014-492789.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/b0ec2a679f66/CRIM.ENDOCRINOLOGY2014-492789.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/06be273e3b33/CRIM.ENDOCRINOLOGY2014-492789.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/e4482cc94b89/CRIM.ENDOCRINOLOGY2014-492789.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/53213d349311/CRIM.ENDOCRINOLOGY2014-492789.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/6e395ddfda23/CRIM.ENDOCRINOLOGY2014-492789.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/b0ec2a679f66/CRIM.ENDOCRINOLOGY2014-492789.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/06be273e3b33/CRIM.ENDOCRINOLOGY2014-492789.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abb4/3929986/e4482cc94b89/CRIM.ENDOCRINOLOGY2014-492789.005.jpg

相似文献

1
FGF23 Producing Mesenchymal Tumor.产生成纤维细胞生长因子23的间充质肿瘤
Case Rep Endocrinol. 2014;2014:492789. doi: 10.1155/2014/492789. Epub 2014 Feb 3.
2
Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.肿瘤诱导的低磷性骨软化症伴三发性甲状旁腺功能亢进:一例报告
G Chir. 2006 Jan-Feb;27(1-2):9-13.
3
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
4
Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.隐匿于众目睽睽之下:基因检测板和遗传标记揭示了一例长达26年未被诊断出的肋骨肿瘤诱导性骨软化症,该病例同时被误诊为X连锁低磷血症。
Bone Rep. 2020 Dec 24;14:100744. doi: 10.1016/j.bonr.2020.100744. eCollection 2021 Jun.
5
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.
6
Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.经影像引导消融治疗引起骨软化症的持续性磷质间叶性肿瘤。
Osteoporos Int. 2021 Sep;32(9):1895-1898. doi: 10.1007/s00198-020-05795-1. Epub 2021 Mar 2.
7
Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.致癌性骨软化症:通过正电子发射断层扫描与计算机断层扫描的联合配准实现肿瘤的精确定位。
J Bone Miner Res. 2007 Jan;22(1):158-62. doi: 10.1359/jbmr.060909.
8
Tumor-induced osteomalacia: experience from a South American academic center.肿瘤相关性骨软化症:来自一家南美学术中心的经验。
Osteoporos Int. 2017 Jul;28(7):2187-2193. doi: 10.1007/s00198-017-4007-2. Epub 2017 Mar 25.
9
[Rickets/Osteomalacia. Diagnosis of tumor-induced osteomalacia.].[佝偻病/骨软化症。肿瘤性骨软化症的诊断。]
Clin Calcium. 2018;28(10):1351-1357.
10
Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia.在一名患有FGF23相关性低磷性骨软化症的患者中,磷替代疗法后骨痛得到显著缓解。
Springerplus. 2016 Nov 2;5(1):1904. doi: 10.1186/s40064-016-3602-6. eCollection 2016.

引用本文的文献

1
CT and MRI Findings of Glomangiopericytoma in the Head and Neck: Case Series Study and Systematic Review.头颈部血管外皮细胞瘤的 CT 和 MRI 表现:病例系列研究和系统评价。
AJNR Am J Neuroradiol. 2020 Jan;41(1):155-159. doi: 10.3174/ajnr.A6336. Epub 2019 Dec 5.
2
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation.成纤维细胞生长因子 23 与胎球蛋白-A 的相互作用及其间充质成骨转化。
Int J Mol Sci. 2019 Feb 20;20(4):915. doi: 10.3390/ijms20040915.
3
Peptide Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor-Induced Osteomalacia.

本文引用的文献

1
Nasal hemangiopericytoma causing oncogenic osteomalacia.鼻腔血管外皮细胞瘤引起的促瘤性骨软化症。
Clin Exp Otorhinolaryngol. 2012 Sep;5(3):173-6. doi: 10.3342/ceo.2012.5.3.173. Epub 2011 Sep 15.
2
Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.肿瘤相关性骨软化症:中国成人发病低磷性骨软化症的重要原因:39 例报告并文献复习。
J Bone Miner Res. 2012 Sep;27(9):1967-75. doi: 10.1002/jbmr.1642.
3
The importance of whole body imaging in tumor-induced osteomalacia.
肽受体放射性核素与奥曲肽:转移性肿瘤诱导骨软化症的一种新方法。
J Endocr Soc. 2017 May 3;1(6):726-730. doi: 10.1210/js.2016-1088. eCollection 2017 Jun 1.
全身成像在肿瘤诱导性骨软化症中的重要性。
J Clin Endocrinol Metab. 2011 Dec;96(12):3599-600. doi: 10.1210/jc.2011-1757.
4
Tumor-induced osteomalacia.肿瘤相关性骨软化症。
Endocr Relat Cancer. 2011 Jun 8;18(3):R53-77. doi: 10.1530/ERC-11-0006. Print 2011 Jun.
5
Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature.鼻窦区磷酸尿性间叶肿瘤:病例报告及文献复习
Head Neck Oncol. 2011 Mar 16;3:16. doi: 10.1186/1758-3284-3-16.
6
Curative surgical treatment after inefficient long-acting somatostatin analogues therapy of a tumor-induced osteomalacia.
Presse Med. 2011 Mar;40(3):309-13. doi: 10.1016/j.lpm.2010.10.011. Epub 2010 Dec 4.
7
The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.成人生长抑素受体瘤中生长抑素受体的水平不足以用其激动剂使血清磷酸盐水平正常化。
Calcif Tissue Int. 2010 Jun;86(6):455-62. doi: 10.1007/s00223-010-9369-9. Epub 2010 May 11.
8
Oncogenic osteomalacia: two case reports with surprisingly different outcomes.致癌性骨软化症:两例结局差异惊人的病例报告。
Arch Orthop Trauma Surg. 2009 Apr;129(4):533-9. doi: 10.1007/s00402-008-0808-2. Epub 2009 Jan 6.
9
A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.一例伴有术前继发性甲状旁腺功能亢进的致癌性骨软化症:FGF23对奥曲肽治疗及手术的生化反应描述
Bone. 2007 Jan;40(1):236-41. doi: 10.1016/j.bone.2006.07.027. Epub 2006 Sep 18.
10
Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.上颌窦间叶肿瘤病例中的致癌性骨软化症。
Am J Med Sci. 2006 Sep;332(3):142-7. doi: 10.1097/00000441-200609000-00010.